淫羊藿苷调节AMPKα1/PPARγ/PGC-1α信号通路对结缔组织病相关间质性肺病模型小鼠免疫炎性损伤的影响
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
目的探究淫羊藿苷对结缔组织病相关间质性肺病(CTD-ILD)模型小鼠免疫炎性损伤的影响,分析其机制是否与AMPKα1/PPARγ/PGC-1α信号通路有关。方法建立CTD-ILD小鼠模型,分为模型组、低、中、高剂量淫羊藿苷组(5、10、20 mg/kg淫羊藿苷)、联合组(20 mg/kg淫羊藿苷+10 mg/kg AMPKα1抑制剂Compound C),每组12只,另外再取12只小鼠作为对照组。小鼠肺组织病理变化情况采用HE染色观察;AMPKα1、PPARγ、PGC-1α mRNA表达采用qRT-PCR法检测;HMGB1、NF-κB p65、TGF-β1、AMPKα1、PPARγ、PGC-1α蛋白表达采用Western blot检测。结果对照组小鼠皮毛顺滑且反应机敏、呼吸平缓、肺组织间质不存在炎症、水肿,肺间隔不存在纤维化;模型组小鼠皮毛干枯粗糙且反应迟缓、呼吸急促、存在水肿、弥漫性肺间质及肺泡炎性细胞浸润,且血管周围存在异常纤维化、肺纤维化病变较弥漫;与对照组相比,模型组IL-10水平降低,AMPKα1、PPARγ、PGC-1α mRNA表达降低,p-AMPKα1/AMPKα1、PPARγ、PGC-1α蛋白表达降低,TNF-α、IL-6水平升高,HMGB1、NF-κB p65、TGF-β1蛋白表达升高(P
Fields of Study & Subjects
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Systemic Sclerosis and Related Diseases
Natural Compounds in Disease Treatment
Publication details
- Journal / source
- DOAJ (DOAJ: Directory of Open Access Journals)
- Publication date
- 1 March 2026
- Language
- ZH